Antimicrobial peptides, such as the cathelicidin LL-37/hCAP-18 and its mouse homolog cathelicidin-related antimicrobial peptide (CRAMP), are important effectors of the innate immune system with direct anti-bacterial activity. Cathelicidin is possibly involved in the regulation of tumor cell growth. The aim of this study was to characterize the role of cathelicidin expressed in non-tumorous cells in a preclinical mouse model of tumor growth. Wild-type and CRAMP-deficient animals were exposed to cigarette smoke (CS) and Lewis lung carcinoma cells were injected to initiate the growth of tumors in the lung. CS exposure significantly increased the proliferation of lung tumors in wild-type mice, but not in CRAMP-deficient mice. CS exposure induced the recruitment of myeloid cell into tumor tissue in a CRAMP-dependent manner. Mice lacking RelA/p65 specifically in myeloid cells showed impaired recruitment of CRAMP-positive cells into the lung. In vitro studies with human cells showed that LL-37/hCAP-18 in macrophages is induced by soluble factors derived from cancer cells. Taken together, these data indicate that cathelicidin expressed from myeloid cells promotes CS-induced lung tumor growth by further recruitment of inflammatory cells. The regulation of cathelicidin expression involves myeloid p65/RelA and soluble factor from tumor cells.
INTRODUCTION
Lung cancer (LC) is one of the deadliest cancer entities and accounts for more than one million deaths per year worldwide. 1 Clinical evidence indicates that inflammation induced by cigarette smoke (CS) is linked with cancer development. Chronic obstructive pulmonary disease is a chronic airway inflammatory disease induced by CS and is associated with increased risk for LC development. 2, 3 It is currently thought that CS-induced inflammation promotes tumor progression through inflammatory factors produced by infiltrating immune cells. 4, 5 The interaction between neoplastic cells and their microenvironment is complex and includes numerous cell types including macrophages, granulocytes, dendritic cells and lymphocytes. 6 Numerous soluble factors secreted by inflammatory cells contribute to the progression of cancer growth. 6 Even though a strong association between inflammation, innate immunity and cancer has been supported by clinical and experimental observations, the cellular mechanisms mediating this relationship remain poorly understood. Antimicrobial peptides (AMPs) are important effector molecules of the innate immune system with direct antimicrobial and various regulatory activities. 7 The human cathelicidin AMP gene CAMP codes for the protein hCAP-18 and is the only known cathelicidin isolated from human cells. Peptides of different lengths are cleaved from hCAP-18. The LL-37 peptide has been studied in most detail. 8 CAMP is expressed by professional host defense cells such as macrophages or neutrophils and epithelial cells of the skin and the gastrointestinal, urinary and respiratory tract. [8] [9] [10] Camp is the homologous gene in mice and codes for the peptide cathelicidin-related AMP (CRAMP), which shows several close structural and functional similarities to LL-37, including an a-helical structure, antimicrobial function and analogous tissue distribution. 11, 12 In addition to their direct antimicrobial activity, cathelicidins are implicated in numerous homeostatic processes, such as wound healing, cell proliferation, angiogenesis or regulation of cell migration. 13, 14 Camp-deficient mice show a breach of innate immunity, 12, 15, 16 and impaired vascularization during wound repair. 17 A growing body of evidence implicates cathelicidins in the promotion of tumor growth. LL-37 contributes to proliferation, invasion and progression of ovarian cancer cells through direct stimulation of tumor cells, initiation of angiogenesis and recruitment of immune cells. 18, 19 LL-37 is overexpressed in breast cancer cells and is considered to be a growth factor for epithelial cells. 20 Camp knockdown in a murine prostate cancer model was associated with decreased proliferation and invasion. 21 Application of LL-37 peptide or transgenic expression of LL-37 in tumor cells results in increased proliferation of LC cells. 22 Conversely, the absence of CRAMP in natural killer cells resulted in increased growth of skin cancers in mice. 23 The aim of this study was to determine whether expression of cathelicidin in myeloid and structural cells of the lung alters the growth of metastatic lung tumors. We studied the effect of CRAMP deficiency in a mouse model of cancer growth and evaluated the factors that regulate the expression of the peptide in the tumor environment.
growth. 22 To investigate the role of CRAMP in the context of local inflammation and expressed from non-tumorous cells in a metastatic LC model, Lewis lung carcinoma cells (LLC) cells were injected in CRAMP-knockout mice (Camp À / À ) and in littermate control mice (wild-type (WT)) followed by smoke exposure ( Figure 1a ). As compared with þ WT animals, Camp À / À mice showed a reduction of the number of macroscopic lung nodules ( Figure 1b ) and lung weight (Figure 1c ). Smoke exposure resulted in enhanced tumor growth in WT mice, whereas Camp À / À mice were protected from smoke-induced tumor growth (Figures 1b   and c) . Macroscopic and microscopic analysis showed that the tumor load of lungs of smoke-exposed WT mice was much higher as compared with lungs of air-exposed Camp À / À mice ( Figure 1d ). In addition, immunohistochemical staining for the proliferation marker Ki-67 showed that the number of Ki-67-expressing cells was significantly increased in tumors from smoke-exposed WT animals as compared with air-exposed WT or Camp À / À mice (Figure 2a ). In the survival analysis, Camp À / À mice exhibited longer survival times than WT mice (Figure 2b ). There was no difference in the survival rates of LLC cells were intravenously injected into sex-matched WT mice and CRAMP À / À mice; at day 7, mice were smoke exposed for 7 days; at day 21, the lungs were removed. The numbers of tumor nodules detectable on the lung surface (b) and lung weight (c) were determined (n ¼ 5, significant difference, **Po0.01; ***Po0.001). air-or smoke-exposed Camp À / À mice. These data show that Camp expression during smoke-induced inflammation and from pulmonary non-tumorous cells is necessary for tumor growth.
CRAMP is required for CS induced influx of myeloid cells into the lung It is well established that cathelicidin functions as chemoattractants for immune cells. 19, 24, 25 We hypothesized that cathelicidin has a role in the CS-induced recruitment and infiltration of immune cells into the lung and into tumor tissue, thereby promoting tumor proliferation and progression. The total cell number as well as the number of macrophages, neutrophils and lymphocytes in bronchoalveolar lavage fluids of WT mice were increased after smoke exposure as compared with air-exposed mice, whereas smoke exposure did not induce the influx of myeloid cells into the lungs of Camp À / À mice (Figures 3a and b ). In addition, the infiltration of macrophages into lung tumors was increased in WT mice but not in Camp À / À mice after smoke exposure as shown by staining for CD68-positive cells (Figure 3c ). These data show that CRAMP has a critical role in directing myeloid cells into the lung and into tumor tissue after smoke exposure.
Smoke induced recruitment of CRAMP-positive immune cells dependents on myeloid RelA/p65 CS induces LC proliferation through activation of myeloid nuclear factor-kB (NF-kB) and subsequent release of inflammatory factors that promote tumor growth. 4 Furthermore, it has been shown that the NF-kB signaling pathway is involved in the regulation of cathelicidin expression. 26 To examine whether NF-kB/RelA mediates the influx of CRAMP-positive immune cells into the lung and into tumor tissue, we exposed myeloid RelA-deficient (rela D À / À ) mice to smoke. As shown earlier, the influx of macrophages and neutrophils in smoke-exposed lungs depends on myeloid p65/RelA. 27 We compared the relative CRAMP mRNA expression in the lungs of air and CS-exposed mice. 
Cancer cells mediate the CS-induced expression of LL-37/hCAP-18 in macrophages
To analyze whether CS induces the expression of cathelicidin, we cocultured human macrophages derived from peripheral blood monocytes with the adenocarcinoma epithelial cell line A549. The coincubation of macrophages with A549 cells induced the expression of CAMP mRNA in macrophages, which was further enhanced by CS extract (CSE) in a dose-dependent manner (Figure 5a ). The expression of LL-37/hCAP18 in A549 cell remained unchanged even when the cells were exposed to CSE, cocultured with macrophages or cocultured with macrophages in combination with CSE ( Figure 5b ). These results indicate that the CS-induced expression of LL-37/hCAP18 is regulated by lung tumor cells. We also studied the regulation of CRAMP in the mouse macrophage cell line RAW264.7 by LLC-conditioned medium or by defined substances such as biglycan and the TLR2-TLR6 ligand Pam2CSK4. As determined by real-time polymerase chain reaction (PCR), conditioned medium from LLC induced the expression of Camp in RAW264.7 cells (Figure 5c ). The effects of biglycan or Pam2CSK4 on CRAMP gene expression were small and rather high doses were required (data not shown). LLC-conditioned medium also induced expression of tumor necrosis factor-a (TNF-a and interleukin (IL)-6 mRNA in RAW264.7 cells (Figure 5c ). These data suggest that tumor-derived, soluble factors regulate the expression of CAMP gene in macrophages.
DISCUSSION
The main finding of this study is that the expression of the AMP cathelicidin in the context of inflammation and in non-tumorous cells is an important factor for lung tumor growth. The peptide is necessary for migration of myeloid cells into the tumor microenvironment. The expression of cathelicidin within the tumor microenvironment depends on myeloid RelA/p65 and is increased by soluble factors derived from tumor cells.
Cathelicidin is secreted by immune and epithelial cells, and acts as a proinflammatory peptide, which links inflammation, host defense, tissue repair and cell growth. 28 Antimicrobial activity is a major function of cathelicidin, it shields mice from skin, urogenital and pulmonary infection, and protects against tuberculosis. 12, 15, 16, 29 Furthermore, cathelicidins have additional functional activity, including chemoattraction, 24, 25, 30 cell activation, 31 and modulation of angiogenesis, 17 inflammation [32] [33] [34] and wound healing. 32, 35 Cathelicidins have also been linked with tumor biology. Several studies demonstrated that the human cathelicidin CAMP is overexpressed in lung, breast, ovarian and prostate cancer cells. 18, [20] [21] [22] Some studies indicate that cathelicidin has a role in suppression of tumor growth. 23, 36 This study highlights the potential role of cathelicidin in the promotion of LC. Expression of the peptide in non-tumorous host cells drives growth of metastatic tumors. Immunohistochemical analysis indicates that myeloid cells are a major source of the CRAMP peptide. Different mechanisms could account for the activity of cathelicidin to increase tumor growth: (1) cathelicidin is known to modulate angiogenesis and to increase tumor vascularization. Our previous studies showed that LL-37 induces angiogenesis by binding of the peptide to FPRL1 in endothelial cells. 17, 37 The peptide also regulates the vascularization in ovarian and prostate cancers, partly through recruitment of multipotent mesenchymal stromal cells. 19, 21 (2) Cathelicidin could also directly modulate the biology of tumor cells. It has been demonstrated that cathelicidin activates epidermal growth factor receptor of tumor cells. 22, 31 (3) Cathelicidin likely also modulates the inflammatory processes in the tumor microenvironment and recruits inflammatory cells. 25 Infiltration of inflammatory cells such as macrophages, neutrophils or lymphocytes is an important characteristic of tumorigenesis, and there is correlation between macrophage abundance and poor prognosis of LC patients. 38 Our data show that CRAMP expression in non-tumorous cells is necessary for efficient macrophage infiltration in the tumor area after CS exposure. Like LL-37, 25 CRAMP exhibits a direct effect on the migration of immune cells including monocytes, neutrophils and macrophages. 24 As these cells also express CRAMP, this mechanism represents an autocrine, positive feedback loop that increases the number of inflammatory cells in the tumor microenvironment ( Figure 6 ).
The regulation of expression of cathelicidin in the context of tumor development is complex. Based on immunohistochemistry, the major cellular source in this model is myeloid cells, cancer or structural cells likely contribute less. This is an important observation as the current knowledge indicates that expression of cathelicidin in tumor cells is important for the activities of the peptide. [18] [19] [20] 22 These data underscore that expression of the peptide in non-tumor, inflammatory cells is important. The impact of inflammation on tumor biology is partly mediated by cathelicidin. The expression of CRAMP is dependent on several factors, including CS exposure, NF-kB activity in myeloid cells and soluble factors released from cancer cells. Expression of the human peptide LL-37/hCAP-18 has been studied in detail and is influenced by inflammation, 10 vitamin D derivates [39] [40] [41] [42] [43] and cell differentiation. 44 The regulation of murine CRAMP likely differs with regard to the susceptibility to vitamin D, as the mouse gene does not contain a vitamin D receptor-response element in the promoter region, while both human and mouse cathelicidin genes are under the influence of parathyroid hormone. The data in this study indicate that soluble factors derived from tumor cells induce the expression of cathelicidin in human and mouse myeloid cells. CAMP in macrophages was upregulated in coculture with A549 cells, and addition of CSE further enhances this effect. Cytokines and growth factors have been reported to induce LL-37/hCAP18 expression such as lipopolysaccharide, IL-1b and insulin-like growth factor-1 in keratinocytes, 46, 47 while several mediators of acute inflammation such as TNF-a, IL-6, IL-8 and interferon-g do not induce expression of LL-37/hCAP18. 39 The depletion of RelA/p65 in myeloid cells results in decreased levels of total Camp transcripts in the lung. The number of CRAMPpositive myeloid cells was significantly decreased in the tumor tissue of rela D À / À mice, while the total number of myeloid cells in the tumor tissue was unchanged. 27 The NF-kB signaling pathway has an important role in the regulation of cathelicidin. Inhibition of NF-kB by small interfering RNA and overexpression of IkBa reduced both basal and induced levels of Camp mRNA in murine mast cells. 26 Analysis of the CRAMP gene sequence shows an NF-kB site present in its promoter region, explaining how NF-kB is implicated in the regulation of CRAMP. 48 It has been recognized earlier that myeloid cells have an important role in tumor progression. 4 The current data indicate that NF-kB-induced cathelicidin production links inflammation and tumor growth.
In conclusion, cathelicidin expression from non-tumorous cells is necessary for lung tumor growth. The peptide likely has diverse direct and indirect effects on tumor cells biology, including increased vascularization, direct cell stimulation and modulation of the tumor microenvironment and inflammation ( Figure 6 ). The major source of cathelicidin is myeloid cells and its regulation is complex. These findings are likely relevant for the situation in LC cancer patients, as the numbers of macrophages are largely increased in the lungs of smokers 49 and concentrations of LL-37/hCAP-18 in sputum are high in patients with chronic obstructive pulmonary disease. 50 Based on the current knowledge on the homology between the human and murine cathelicidins, the mechanisms described here, in vitro and in vivo mouse models, likely are involved in human LC development.
MATERIALS AND METHODS

Animal and cell culture
Camp À / À mice were described earlier. 12 To generate a constitutive knockout of RelA/p65 in myeloid cells, rela F/F mice were crossed with LysMCre animals to generate a rela F/F LysMCre mouse line. 51 The rela wt/wt LysMCre (rela wt/wt ) mice were used as control mice. All strains used in tumor studies were C57BL/6 background. Mice were maintained under a pathogen-free condition, and all animal experiments were approved by the Landesamt fü r Soziales, Gesundheit und Verbraucherschutz of the State of Saarland, following the national guidelines for ethical animal treatment.
The human lung adenocarcinoma cell line A549, mouse LLC cells and the mouse macrophage cell line RAW264.7 cells were cultured in Dulbeccos's modified Eagle's medium (DMEM) (Invitrogen, Grand Island, NY, USA), supplemented with 10% fetal calf serum (Invitrogen, Grand Island, NY, USA), 100 U/ml penicillin and 100 U/ml streptomycin (PAA Laboratories GmbH, Pasching, Austria). Human primary macrophages were generated as described previously. 52 Briefly, human peripheral blood mononuclear cells from healthy donors were isolated from buffy coats by Ficoll-paque PLUS (GE Healthcare, Uppsala, Sweden) density centrifugation. Mononuclear cells were cultured in DMEM supplemented with 1% human serum for 1 h at 37 1C, after which the nonadherent cells were removed by vigorous washing with phosphate-buffered saline. Adherent cells were cultured in fresh DMEM (contain 10% fetal calf serum) supplemented with 50 ng/ml macrophage colony-stimulating factor (eBioscience, San Diego, CA, USA) for 7 days to allow differentiation to macrophages.
Murine LC metastasis model
An LC metastasis model in mouse was generated by intravenous injection of LLC cells (Figure 1a) . Subconfluent LLC cells were harvested and passed through a 40-mm cell strainer (BD Biosciences, Bedford, MA, USA), washed three times in phosphate-buffered saline, resuspended in serum-free DMEM and inoculated at 2 Â 10 5 or 5 Â 10 5 cells per mice by the tail vein. After 7 days, mice were exposed to mainstream CS or filtered air. To expose animals to smoke, mice were placed in a plexiglas smoke box and exposed to CS generated by burning 3R4F reference cigarettes (College of Agriculture, Reference Cigarette Program, University of Kentucky, Lexington, KY, USA) using a smoking machine (Ugo Basile 7025 rodent ventilator; Ugo Basile Srl, Comerio, VA, Italy). The average total suspended particulate matter in the chamber was 400±15 mg/m 3 . Mice were exposed to CS for 20 min per time, five times per day for 7 days, followed by 7 days rest. Control groups were incubated with filtered air. After euthanasia, the lungs were lavaged, removed, weighed and fixed for histological examination. Lung tumor nodules were carefully counted under a dissection microscope. The entire tumor-bearing lung was used for RNA analysis. Bronchoalveolar lavage fluid was obtained as described previously. 53 Preparation of CSE CSE was prepared by bubbling smoke from 3R4F reference cigarette into 20 ml of serum-free DMEM at a rate of 1 cigarette/min. This medium (100%) was adjusted to pH 7.4, and was sterile filtered. After preparations, CSE stock solutions were frozen in aliquots at À 80 1C. 
Cell culture
For coculture human monocyte-derived macrophages (4 Â 10 5 cells) were seeded into the bottom of 6-well plates and A549 cells (2 Â 10 5 cells) were placed in transwell inserts (0.4 mm; Becton Dickinson and Company, Franklin Lakes, NJ, USA) and cultured in DMEM with 10% FBS. For CSE stimulation, the cells were stimulated with 0, 0.25 or 0.5% CSE for 48 h. For experiments with murine cells, the medium was collected from LLC cells incubated in serum-free DMEM for 24 h, filtered through a 0.2 mm filter and added to RAW264.7 cells for 24 h, after which CRAMP, TNF-a and IL-6 mRNA levels were measured.
Histologic and immunohistochemical analyses
The following primary antibodies were used for immunohistochemical analysis: rabbit anti-Ki-67 (Abcam, Cambridge, UK), rabbit anti-CD68 (Abbiotec, San Diego, CA, USA) and rabbit anti-CRAMP (Pineda-Antikö rper-Service, Berlin, Germany). The lungs were infused with 4% paraformaldehyde (Carl Roth, Karlsruhe, Germany) and placed in 4% paraformaldehyde for 24 h. Tissues were embedded in paraffin, sectioned and stained with hematoxylin and eosin. For immunohistochemical analysis, sections were deparaffinized and boiled for 20 min in 0.01 M citrate buffer (pH 6.0) for antigen retrieval. Unspecific tissue peroxidases were blocked by 3% (v/v) H 2 O 2 , followed by incubation in blocking solution (2% bovine serum albumin in TBS-T, Tris-buffered saline containing 0.1% Tween-20) for 60 min. Sections were incubated with primary antibodies in 4 1C overnight. Biotinylated secondary antibodies were added, followed by an avidin-horseradish peroxidase reagent (EnVision System (AEC), DAKO, Glostrup, Denmark). The sections were counterstained with hematoxylin and mounted. The number of Ki-67-positive tumor cells and the total number of tumor cells was enumerated in six microscopic fields of randomly selected tumor and the mean value was calculated as the percentage of Ki-67-positive tumor cells.
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Statistical analysis
Data are expressed as mean±s.e.m. The data were analyzed using a two-tailed unpaired Student's t-test or Kaplan-Meier survival analysis.
A P-value of o 0.05 was considered statistically significant.
